Blood and urine tests to study heart risk in kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks for new markers in blood or urine that may help explain heart (cardiovascular) risk in people with chronic kidney disease. It may help doctors better predict risk, especially in those not yet on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a written consent form to join
- You have chronic kidney disease but you are not on dialysis
- Your kidney function is described by a lab measure called GFR (glomerular filtration rate)
- You cannot be pregnant
- You must not need dialysis treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart (cardiovascular) risk factors in people who are just starting dialysis for chronic kidney failure. It may help doctors better understand what heart-related issues to watch for early during dialysis.
This study is looking at the link between kidney disease and heart disease. It aims to understand how heart problems affect people with chronic kidney disease. The trial does not test a new drug, but rather follows patients to learn more about their health.
This study looks at how bone structure and blood-vessel calcification change before and after a kidney transplant. It may help doctors better understand what to monitor for long-term health after transplantation.
This study measures how blood vessels behave in people with kidney disease or at risk for it. Researchers will use special sensors to understand how vessel stiffness changes, which could help predict and prevent heart and kidney problems.
This study looks at heart imaging scans in people with kidney disease to find early signs of heart problems. Researchers will use special imaging already planned as part of your normal care to see if it can help identify who needs heart treatment.
This study looks at a protein called lipoprotein(a) in the blood to see if it predicts heart problems in people with stage 4 chronic kidney disease who are not on dialysis or transplant. Following participants for 18 months, it aims to find ways to better manage heart risk.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.